PR agency WE Communications has set up a new scientific engagement and medical education offering and recruited Terry Bradley and Ben Fisher to lead it.
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS